Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BN.1.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DJ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19429.5South Korea
BE.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BE.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.66EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
BA.5.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used